Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - NovaBay Pharmaceuticals, Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - NovaBay Pharmaceuticals, Inc. | nby20140930_10q.htm |
EX-31 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc. | ex31-2.htm |
EX-31 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc. | ex31-1.htm |
EX-32 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc. | ex32-1.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of NovaBay Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 12, 2014
|
/s/ Thomas J. Paulson |
Thomas J. Paulson |
Chief Financial Officer |